April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Long-Term Outcomes of Selective Laser Trabeculoplasty in Patients with Uveitis
Author Affiliations & Notes
  • F. Zakka
    Occular Immunology, MA Eye Research and Surgery Institution, Cambridge, Massachusetts
  • S. Pujari
    Occular Immunology, MA Eye Research and Surgery Institution, Cambridge, Massachusetts
  • M. Shaikh
    Occular Immunology, MA Eye Research and Surgery Institution, Cambridge, Massachusetts
  • E. Yuksel
    Occular Immunology, MA Eye Research and Surgery Institution, Cambridge, Massachusetts
  • D. Hinkle
    Occular Immunology, MA Eye Research and Surgery Institution, Cambridge, Massachusetts
  • C. S. Foster
    Occular Immunology, MA Eye Research and Surgery Institution, Cambridge, Massachusetts
  • Footnotes
    Commercial Relationships  F. Zakka, None; S. Pujari, None; M. Shaikh, None; E. Yuksel, None; D. Hinkle, None; C.S. Foster, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 159. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Zakka, S. Pujari, M. Shaikh, E. Yuksel, D. Hinkle, C. S. Foster; Long-Term Outcomes of Selective Laser Trabeculoplasty in Patients with Uveitis. Invest. Ophthalmol. Vis. Sci. 2009;50(13):159.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To assess the effectiveness of selective laser trabeculoplasty (SLT) in lowering intraocular pressure (IOP) in patients with uveitis.

Methods: : A Retrospective chart review was conducted of 61 patients (69 eyes) with uveitis and IOP elevation at the Massachusetts Eye Research and Surgery Institution. Outcomes of SLT, including IOP and number of uveitis flare-ups, were assessed at 1, 3, 6 and 12 months following the procedure.

Results: : Among the 69 eyes treated with SLT, 40 eyes (58%), 4 eyes (5.8%), and 25(36.2%) had anterior uveitis, intermediate uveitis, and posterior or panuveitis respectively. The total number of eyes that were followed-up at 1, 3, 6, and 12 months was 56, 54, 54 and 26 respectively. The mean intra-ocular pressure reduction from baseline at 1,3,6 and 12 months was 15.8%, 20.3%, 21.3% and 23.0% respectively, which was significant. The mean number of uveitis flare-ups following SLT at 1, 3, 6, and 12 months was 0.36, 0.25, 0.35, 0.58 respectively. Six eyes required other glaucoma surgery to control IOP.

Conclusions: : SLT significantly lowered IOP at all follow-up visits. This procedure can be used effectively as an adjunctive therapy for patients with uveitic glaucoma.

Keywords: intraocular pressure • laser • uveitis-clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×